ResMed has a total of 9171 patents globally, out of which 6252 have been granted. Of these 9171 patents, more than 63% patents are active. The United States of America is where ResMed has filed the maximum number of patents, followed by Australia and Japan. Parallelly, United States of America seems to be the main focused R&D center and also is the origin country of ResMed.
ResMed was founded in 1989. ResMed develops, manufactures, and markets medical equipment for the treatment of sleep disordered breathing. The Company sells diagnostic and treatment devices in various countries through its subsidiaries and independent distributors. As of June 2022, ResMed has a market cap of $30.51 Billion.
Read about some of the most popular patents of ResMed which have been covered by us in this article and also you can find ResMed patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over ResMed patent portfolio.
How many patents does the Founder and CEO of ResMed have?
The Founder Peter Farrell has 21 patents and the CEO Michael J. Farrell has 0 patents.
How many patents does ResMed have?
ResMed has a total of 9171 patents globally. These patents belong to 1907 unique patent families. Out of 9171 patents, 5795 patents are active.
How Many Patents did ResMed File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | ResMed Applications Filed | ResMed Patents Granted |
2011 | 286 | 284 |
2012 | 436 | 326 |
2013 | 518 | 319 |
2014 | 693 | 388 |
2015 | 385 | 458 |
2016 | 419 | 435 |
2017 | 371 | 375 |
2018 | 250 | 323 |
2019 | 398 | 464 |
2020 | 578 | 484 |
2021 | 405 | 471 |
2022 | 58 | 203 |
How many ResMed patents are Alive/Dead?
Worldwide Patents
How Many Patents did ResMed File in Different Countries?
Countries in which ResMed Filed Patents
Country | Patents |
United States Of America | 2377 |
Australia | 1282 |
Japan | 1054 |
New Zealand | 1000 |
China | 960 |
Europe | 954 |
Germany | 404 |
United Kingdom | 114 |
Taiwan | 99 |
Spain | 55 |
Austria | 51 |
Hong Kong (S.A.R.) | 38 |
Canada | 37 |
France | 25 |
Mexico | 20 |
Korea (South) | 17 |
India | 13 |
Singapore | 11 |
Sweden | 10 |
Brazil | 6 |
Malaysia | 6 |
Switzerland | 4 |
Czech Republic | 3 |
Israel | 3 |
Italy | 2 |
Indonesia | 1 |
Russia | 1 |
Montenegro | 1 |
Poland | 1 |
Colombia | 1 |
Where are Research Centers of ResMed Patents Located?
10 Best ResMed Patents
US6581594B1 is the most popular patent in the ResMed portfolio. It has received 764 citations so far from companies like Molex Incorporated, Topconn Electronic and Te Connectivity Corporation.
Below is the list of 10 most cited patents of ResMed:
Publication Number | Citation Count |
US6581594B1 | 764 |
WO2004073778A1 | 761 |
US6532959B1 | 738 |
WO2005063328A1 | 729 |
WO2009052560A1 | 711 |
WO2006130903A1 | 710 |
US6374826B1 | 652 |
US6532961B1 | 649 |
WO2010135785A1 | 549 |
US6412487B1 | 494 |
Which Companies are using ResMed Patents to Advance their Research?
If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.
The top citing companies in the ResMed patent portfolio are Philips, Fisher & Paykel Healthcare and Covidien.
List of the top forward citing Companies –
Company | Number of Patents |
Philips | 251 |
Fisher & Paykel Healthcare | 197 |
Covidien | 28 |
Loewenstein Medical Technology Sa | 25 |
Breathe Technologies Inc | 24 |
Samsung Electronics | 20 |
IBM | 20 |
General Electric | 16 |
3M Innovative Properties Company | 15 |
Drägerwerk Ag & Co | 15 |
Count of 102 and 103 Type Rejections based on ResMed Patents
Top ResMed Patents used in Rejecting Most Patent Applications
Patent Number | Count of Rejected Applications |
US20070067373A1 | 49 |
US8562526B2 | 42 |
US10376670B2 | 30 |
US9480809B2 | 27 |
US8454528B2 | 26 |
US7318437B2 | 25 |
US20070249952A1 | 24 |
US8450898B2 | 22 |
US8297285B2 | 21 |
US20070011334A1 | 21 |
US8291906B2 | 20 |
US10092720B2 | 19 |
US9855398B2 | 17 |
US9132255B2 | 16 |
US7971590B2 | 16 |
What Percentage of ResMed US Patent Applications were Granted?
ResMed (Excluding its subsidiaries) has filed 1751 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1223 have been granted leading to a grant rate of 90.8%.
Below are the key stats of ResMed patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for ResMed?
Law Firm | Total Applications | Success Rate |
Nixon & Vanderhye Pc | 1223 | 91.12% |
Botos Churchill Ip Law Llp | 363 | 94.74% |
Fish & Richardson Pc | 56 | 93.48% |
Lerner David Littenberg | 45 | 73.81% |
Nixon Peabody Llp | 15 | 50.00% |
Pillsbury Winthrop Shaw Pittman Llp | 11 | 75.00% |
Shay Glenn Llp | 8 | 100.00% |
Gottlieb Rackman & Reisman Pc | 7 | 66.67% |
George W Rauchfuss Jr | 5 | 100.00% |
Jones Day | 3 | 66.67% |
EXCLUSIVE INSIGHTS COMING SOON!